SEC Form 4 · accession 0001179110-16-017212
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott D Morenstein
Director
Period of report
Jan 1, 2016
Accepted (ET)
Jan 5, 2016 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2016 | A | 17,857 | $0.00 | A | 17,857 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 50% of the shares on each of March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.